Picture of Redhill Biopharma logo

RDHL — Redhill Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: RedHill Announces New Patent Covering Opaganib In Combination With Immune Checkpoint Inhibitors

June 3 (Reuters) - Redhill Biopharma Ltd  2RH0y.F :
    * REDHILL ANNOUNCES A NEW PATENT COVERING OPAGANIB IN
COMBINATION
WITH IMMUNE CHECKPOINT INHIBITORS, VALID THROUGH 2040

Source text for Eikon:  ID:nPn9L62r7a 
Further company coverage:  2RH0y.F 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Redhill Biopharma

See all news